Joseph Shiloach, Ph.D.


Head, Biotechnology Core Lab
BIOTECHNOLOGY CORE
NIDDK, National Institutes of Health
Building 14A , Room 173
14 Service Rd West.
Bethesda, MD 20814
Tel: 301-496-9719
Fax: 301-451-5911
Email: josephs@intra.niddk.nih.gov

Education / Previous Training and Experience:
B.S., Hebrew University, Jerusalem, 1968
M.S., Hebrew University, Jerusalem, 1970
Ph.D., Hebrew University, Jerusalem, 1975


Research Statement:

The Laboratory’s main interest is production and purification of biological products from both prokaryotes and eukaryotes of native and recombinant strains. Our work involves all aspects of this process including research, development, and production. To accomplish this mission, the Laboratory includes a pilot production facility that is well-equipped with recovery and purification equipments and bioreactors of various sizes and configurations for propagation of biological systems such as mammalian cells, insect cells, bacteria, yeast, and fungi. The biological products we make support clinical and structural studies.

The Laboratory conducts research and process development based on growth optimization, production scale-up and product recovery processes. We concentrate on protein production and purification with an emphasis on scaling up. One of the current research topics is aimed to achieve better understanding of the growth behavior and metabolism of both E. coli and several mammalian cell lines. The objective is to be able to overcome specific difficulties in the growth and the production process by modifying the properties of the producers. This work involved with gene transcription and expression analysis as well as cells transfection and mutation. Our recent achievement is identifying genes involve in mammalian cell adhesion, which allow us to modify the way the cells grow.



Selected Publications:

Druz A, Chia C, Majors B, Santuary R, Betenbaugh M, Shiloach J. A novel microRNA mmu-mir-466h affects apoptosis regulation in mammalian cells. Biotechnology and Bioengineering. 108(7);1651-1661, 2011. [Full Text/Abstract]

Chu C, Lugovtsev V, Leuis A, Betenbaugh M, Shiloach J. Production and antigenic properties of influenza virus from suspension MDCK–siat7e cells in a bench-scale bioreactor. Vaccine. 28(44);7193-7201, 2010. [Full Text/Abstract]

Negrete A, Ng WI, Shiloach J. Glucose uptake regulation in E. coli by the small RNA SgrS: comparative analysis of E. coli K-12 (JM109 and MG1655) and E. coli B (BL21). Microbial Cell Factories 9;75, 2010. [Full Text/Abstract]

Shiloach J, Reshamwala S, Noronha SB, Negrete A. Analyzing metabolic variations in different bacterial strains, historical perspectives and current trends- example E. coli. Current Opinion in Biotechnology. 21(1);1-6, 2010. [Full Text/Abstract]

Chu C, Lugovtsev V, Golding H, Betenbaugh M, Shiloach J. Conversion of MDCK cell line to suspension culture by transfecting with human siat7e gene and its application for influenza virus production. Proceedings of the National Academy of Sciences USA 106;14802-14807, 2009. [Full Text/Abstract]

Shiloach J, Rinas U. Glucose and acetate metabolism in E. coli-system level analysis and biotechnological applications in protein production processes. In: Lee SY, ed. System Biology and Biotechnology of E. coli. Springer; 377-400, 2009.

Chill L, Trinh L, Azadi P, Ishihara M, Sonon R, Karnaukhova K, Ophir Y, Golding B, Shiloach J. Production, purification, and characterization of human α1 proteinase inhibitor from Aspergillus. Biotechnology and Bioengineering. 102(3);828-844, 2009. [Full Text/Abstract]

Jaluria P, Betenbaugh M, Konstantopoulos K, Frank B, Shiloach J. Application of microarrays to identify and characterize genes involved in attachment dependence in HeLa cells. Metabolic Engineering. 9(3);241-257, 2007. [Full Text/Abstract]

Jaluria P, Chu C, Betenbaugh M, Shiloach J. Cells by design: a mini-review of targeting cell engineering using DNA microarrays. Molecular Biotechnology. 39(2);105-111, 2008. [Full Text/Abstract]

Phue JN, Lee SJ, Trinh L, Shiloach J. Modified E. coli B (BL21), a superior producer of plasmid DNA compared with E. coli K (DH5α). Biotechnology and Bioengineering. 101(4);831-836, 2008. [Full Text/Abstract]

Phue Je-Nie, Kedem B, Jaluria P, Shiloach J. Evaluating microarrays using semiparametric approach: Application to the entral carbon metabolism of E. coli BL21and JM109. Genomics. 89(2);300-305, 2007. [Full Text/Abstract]

Jaluria P, Betenbaugh M, Konstantopoulos K, Shiloach J. Enhancement of cell proliferation in various mammalian cell lines by gene insertion of a cyclin-dependent kinase homolog. BMC Biotechnology. 7;71, 2007. [Full Text/Abstract]

Shiloach J, Fass R. Growing E.coli to high cell density — a historical perspective on method development. Biotechnology Advances. 23(5);345-357, 2005. [Full Text/Abstract]




Update My page

Page last updated: December 16, 2011

General inquiries may be addressed to:
Office of Communications & Public Liaison
NIDDK, NIH
Bldg 31, Rm 9A06
31 Center Drive, MSC 2560
Bethesda, MD 20892-2560
USA
301.496.3583

The National Institutes of Health   Department of Health and Human Services   USA.gov is the U.S. government's official web portal to all federal, state, and local government web resources and services.  This website is certified by Health On the Net Foundation. Click to verify.